Company
Montara Therapeutics
Also known as Montara Therapeutics, Inc
- Business model
- B2B
- Legal name
- Montara Therapeutics, Inc
Claim, correct or request removal
Record updated 29 September 2026
About
Montara is leveraging its BrainOnly™ platform designed prevent peripheral toxicities and concentrate neurological drugs’ activity in the brain.
Funding snapshot
- Total raised
- $28MSEC form D sum, as of 2026-09-29Source (opens in a new tab)
- Latest round
- Round, $20M2025-02-26
Funding rounds
- Round, 2025
- $20M2025-02-26, SEC form D sold, 9 investors
- Round, 2024
- $8M2024-01-05, SEC form D sold, 5 investors
Loading relationship preview